The Health and Economic Benefits of Influenza Vaccination for Healthy and At-Risk Persons Aged 65 to 74 Years

被引：0
作者：
Kristin L. Nichol
Michael Goodman
机构：
[1] University of Minnesota and Minneapolis VA Medical Center (111),
[2] Health Partners Research Foundation,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Influenza; Adis International Limited; Influenza Vaccine; Influenza Vaccination; Healthy Person;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The objective of this study was to assess the health and economic benefits of influenza vaccination in both healthy and at-risk seniors aged 65 to 74 years.
引用
收藏
页码：63 / 71
页数：8
相关论文
共 43 条
  • [41] Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis
    Levin, Myron J.
    Divino, Victoria
    Shah, Drishti
    DeKoven, Mitch
    Mould-Quevedo, Joaquin
    Pelton, Stephen, I
    Postma, Maarten J.
    VACCINES, 2021, 9 (10)
  • [42] Illness representations on pneumonia and pneumococcal vaccination uptake among community-living Chinese people with high-risk conditions aged ≥65 years --- a population-based study
    Wang, Zixin
    Fang, Yuan
    Dong, Willa
    Lau, Mason
    Mo, Phoenix K. H.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) : 1455 - 1462
  • [43] Underlying cardiopulmonary conditions as a risk factor for influenza and respiratory syncytial virus infection among community-dwelling adults aged ≥ 65 years in Thailand: Findings from a two-year prospective cohort study
    Praphasiri, Prabda
    Shrestha, Manash
    Patumanond, Jayanton
    Nakphook, Sutthichai
    Chawalchitiporn, Sutthinan
    Ditsungnoen, Darunee
    Dawood, Fatimah S.
    Mott, Joshua A.
    Prasert, Kriengkrai
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (05) : 634 - 640
12345